Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2011

01-10-2011 | IM - Original

Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia

Authors: Marco Falcone, Salvatore Corrao, Mario Venditti, Pietro Serra, Giuseppe Licata

Published in: Internal and Emergency Medicine | Issue 5/2011

Login to get access

Abstract

The objective was to compare three score systems, pneumonia severity index (PSI), the Confusion-Urea-Respiratory Rate-Blood pressure-65 (CURB-65), and severe community-acquired pneumonia (SCAP), for prediction of the outcomes in a cohort of patients with community-acquired (CAP) and healthcare-associated pneumonia (HCAP). Large multi-center, prospective, observational study was conducted in 55 hospitals. HCAP patients were included in the high classes of CURB-65, PSI and SCAP scores have a mortality rate higher than that of CAP patients. HCAP patients included in the low class of the three severity rules have a significantly higher incidence of adverse events, including development of septic shock, transfer into an ICU, and death (p < 0.01). At multivariate Cox regression analysis, inclusion in the severe classes of PSI, CURB-65, or SCAP scores and receipt of an empirical therapy not adherent to international guidelines prove to be risk factors independently associated with poor outcome. PSI, CURB-65, and SCAP score have a good performance in patients with CAP but are less useful in patients with HCAP, especially in patients classified in the low-risk classes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Venditti M, Falcone M, Corrao S et al (2009) Comparison of the outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 150:19–26PubMed Venditti M, Falcone M, Corrao S et al (2009) Comparison of the outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 150:19–26PubMed
2.
go back to reference Zilberberg MD, Shorr AF, Micek ST et al (2008) Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest 134:963–968PubMedCrossRef Zilberberg MD, Shorr AF, Micek ST et al (2008) Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest 134:963–968PubMedCrossRef
3.
go back to reference Shorr AF, Zilberberg MD, Micek ST, Kollef MH (2008) Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 168:2205–2210PubMedCrossRef Shorr AF, Zilberberg MD, Micek ST, Kollef MH (2008) Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 168:2205–2210PubMedCrossRef
4.
go back to reference Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250PubMedCrossRef Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250PubMedCrossRef
5.
go back to reference Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382PubMedCrossRef Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377–382PubMedCrossRef
6.
go back to reference Espana PP, Capelastegui A, Gorordo I et al (2006) Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174:1249–1256PubMedCrossRef Espana PP, Capelastegui A, Gorordo I et al (2006) Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 174:1249–1256PubMedCrossRef
7.
go back to reference Shindo Y, Sato S, Maruyama E et al (2008) Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 13:731–735PubMedCrossRef Shindo Y, Sato S, Maruyama E et al (2008) Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology 13:731–735PubMedCrossRef
8.
go back to reference Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72PubMedCrossRef Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72PubMedCrossRef
9.
go back to reference American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef
10.
go back to reference Micek ST, Kollef KE, Reichley RM et al (2007) Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51:3568–3573PubMedCrossRef Micek ST, Kollef KE, Reichley RM et al (2007) Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51:3568–3573PubMedCrossRef
11.
go back to reference Shindo Y, Sato S, Maruyama E et al (2009) Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 135:633–640PubMedCrossRef Shindo Y, Sato S, Maruyama E et al (2009) Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 135:633–640PubMedCrossRef
12.
go back to reference Falcone M, Venditti M, Corrao S, Serra P for the SIMI (2011) Role of multidrug-resistant pathogens in health care-associated pneumonia. Lancet Infect Dis 11:12–13 Falcone M, Venditti M, Corrao S, Serra P for the SIMI (2011) Role of multidrug-resistant pathogens in health care-associated pneumonia. Lancet Infect Dis 11:12–13
Metadata
Title
Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia
Authors
Marco Falcone
Salvatore Corrao
Mario Venditti
Pietro Serra
Giuseppe Licata
Publication date
01-10-2011
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 5/2011
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0521-y

Other articles of this Issue 5/2011

Internal and Emergency Medicine 5/2011 Go to the issue

CE - MEDICAL ILLUSTRATION

Gas around the bladder

CE - Letter to the Editor

QTc pseudoprolongation

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.